Amgen | AMGN

Stock Price
366.42
Daily Change
1.77 0.49%
Monthly
12.56%
Yearly
24.18%
Q1 Forecast
372.52



Peers Price Chg Day Year Date
Takeda 5,581.00 77.00 1.40% 37.13% Feb/10
AbbVie 221.16 -1.28 -0.58% 14.59% Feb/11
Agios Pharmaceuticals 26.64 -0.49 -1.81% -18.43% Feb/11
ALKERMES 33.92 -0.80 -2.30% 6.13% Feb/11
Amgen 366.42 1.77 0.49% 24.18% Feb/11
Biogen 191.38 2.39 1.26% 37.30% Feb/11
BioMarin Pharmaceutical 60.60 0.94 1.58% -4.64% Feb/11
Bristol-Myers Squibb 60.83 -0.03 -0.05% 8.33% Feb/11
Coherus Biosciences 2.02 -0.09 -4.27% 81.98% Feb/11
Exelixis 42.17 -0.81 -1.88% 28.57% Feb/11

Indexes Price Day Year Date
US500 6960 17.94 0.26% 15.00% Feb/11
USND 23095 -7.00 -0.03% 17.53% Feb/11
US30 50224 36.06 0.07% 13.20% Feb/11
US100 25220 92.14 0.37% 16.12% Feb/11

Amgen traded at $366.42 this Wednesday February 11th, increasing $1.77 or 0.49 percent since the previous trading session. Looking back, over the last four weeks, Amgen gained 12.56 percent. Over the last 12 months, its price rose by 24.18 percent. Looking ahead, we forecast Amgen to be priced at 372.52 by the end of this quarter and at 339.25 in one year, according to Trading Economics global macro models projections and analysts expectations.

Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It operates in human therapeutics segment. Its marketed products portfolio includes ENBREL, Prolia (denosumab), Neulasta (pegfilgrastim), Otezla, XGEVA, Aranesp (darbepoetin alfa), KYPROLIS, Repatha (evolocumab), Nplate (romiplostim), Vectibix (panitumumab), MVASI (bevacizumab-awwb), Parsabiv (etelcalcetide), EPOGEN (epoetin alfa), KANJINTI (trastuzumab-anns), BLINCYTO (blinatumomab), Aimovig (erenumab-aooe), EVENITY (romosozumab-aqqg), AMGEVITATM (adalimumab), Sensipar/Mimpara (cinacalcet), NEUPOGEN (filgrastim), IMLYGIC (talimogene laherparepvec), Corlanor (ivabradine) and AVSOLA (infliximab-axxq). It focuses on human therapeutics for the treatment of serious illness in the areas of inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology and neuroscience.



News Stream
Amgen Stock Price Hits All-time High
Amgen shares increased to an all-time high of 355.51 USD. Over the past 4 weeks, Amgen gained 5.57%, and in the last 12 months, it increased 17.15%.
2026-02-04
Amgen Stock Price Hits 6-week High
Amgen shares increased to 343.05 USD, the highest since December 2025. Over the past 4 weeks, Amgen gained 3.47%, and in the last 12 months, it increased 25.39%.
2026-01-21
Amgen Stock Price Hits 4-week High
Amgen shares increased to 335.43 USD, the highest since December 2025. Over the past 4 weeks, Amgen gained 2.78%, and in the last 12 months, it increased 25.99%.
2026-01-07